These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36966601)

  • 1. Racial disparities in pregnancy outcomes among women with rheumatic diseases: A systematic literature review.
    Shen G; Swaminathan M; Huang I; Louden D; Feterman D; Tahir MW; Singh N
    Semin Arthritis Rheum; 2023 Jun; 60():152193. PubMed ID: 36966601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial/ethnic disparities in the risk of preterm birth among women with systemic lupus erythematosus or rheumatoid arthritis.
    Strouse J; Sabih L; Bandoli G; Baer R; Jelliffe-Pawlowski L; Chambers C; Ryckman K; Singh N
    Clin Rheumatol; 2023 Sep; 42(9):2437-2444. PubMed ID: 37099120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of adverse pregnancy outcomes prior to the onset of an autoimmune rheumatic disease: a systematic review.
    Muñoz CM; Goulden B; Ahmed K; Alijotas-Reig J; Giles I
    Rheumatology (Oxford); 2023 Feb; 62(2):497-511. PubMed ID: 35929796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.
    Kaplowitz ET; Ferguson S; Guerra M; Laskin CA; Buyon JP; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Merrill JT; Katz P; Salmon JE
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):230-235. PubMed ID: 28480528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan.
    Sugawara E; Kato M; Fujieda Y; Oku K; Bohgaki T; Yasuda S; Umazume T; Morikawa M; Watari H; Atsumi T
    Lupus; 2019 Oct; 28(12):1407-1416. PubMed ID: 31551035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update.
    Li X; Shopit A; Wang J
    Arch Gynecol Obstet; 2021 Nov; 304(5):1153-1160. PubMed ID: 34390384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
    Buyon JP; Kim MY; Guerra MM; Laskin CA; Petri M; Lockshin MD; Sammaritano L; Branch DW; Porter TF; Sawitzke A; Merrill JT; Stephenson MD; Cohn E; Garabet L; Salmon JE
    Ann Intern Med; 2015 Aug; 163(3):153-63. PubMed ID: 26098843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Disparities in the Pregnancies of Women With Systemic Lupus Erythematosus.
    Clowse ME; Grotegut C
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1567-72. PubMed ID: 26815791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preeclampsia on infant and maternal health among women with rheumatic diseases.
    Milne ME; Clowse ME; Zhao C; Goldstein BA; Eudy AM
    Lupus; 2024 Apr; 33(4):397-402. PubMed ID: 38413920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes.
    Castellanos Gutierrez AS; Figueras F; Espinosa G; Youssef L; Crispi F; Santana M; Nadal A; Baños N
    Placenta; 2023 Aug; 139():92-98. PubMed ID: 37354691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse pregnancy outcomes in women with systemic lupus erythematosus: can we improve predictions with machine learning?
    Fazzari MJ; Guerra MM; Salmon J; Kim MY
    Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36104120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.
    Kim MY; Guerra MM; Kaplowitz E; Laskin CA; Petri M; Branch DW; Lockshin MD; Sammaritano LR; Merrill JT; Porter TF; Sawitzke A; Lynch AM; Buyon JP; Salmon JE
    Ann Rheum Dis; 2018 Apr; 77(4):549-555. PubMed ID: 29371202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatic diseases in pregnancy].
    Märker-Hermann E; Bauer H; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2410-4. PubMed ID: 18988134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with autoimmune skin diseases are at increased risk of adverse pregnancy outcomes.
    Keum H; Bermas B; Patel S; Jacobe HT; Chong BF
    Am J Obstet Gynecol MFM; 2024 Jan; 6(1):101226. PubMed ID: 37972926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center.
    Barilaro G; Castellanos A; Gomez-Ferreira I; Lledó GM; Della Rocca C; Fernandez-Blanco L; Cervera R; Baños N; Figueras F; Espinosa G
    Arthritis Res Ther; 2022 Apr; 24(1):91. PubMed ID: 35477585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome.
    Castro-Gutierrez A; Young K; Bermas BL
    Rheum Dis Clin North Am; 2022 May; 48(2):523-535. PubMed ID: 35400376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 study.
    Larosa M; Le Guern V; Guettrot-Imbert G; Morel N; Abisror N; Morati-Hafsaoui C; Orquevaux P; Diot E; Doria A; Sarrot-Reynauld F; Limal N; Queyrel V; Souchaud-Debouverie O; Sailler L; Le Besnerais M; Goulenok T; Molto A; Pannier-Metzger E; Sentilhes L; Mouthon L; Lazaro E; Costedoat-Chalumeau N;
    Rheumatology (Oxford); 2022 Aug; 61(9):3657-3666. PubMed ID: 35015828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
    Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG
    Ann Rheum Dis; 2022 Jun; 81(6):768-779. PubMed ID: 35110331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.